Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
Jefferies (JEF) delivered earnings and revenue surprises of -5.51% and -0.61%, respectively, for the quarter ended May 2026. Do the numbers hold clues to what lies ahead for the stock?
Anthropic has accused Chinese ecommerce giant Alibaba of obtaining illicit access to Claude by creating fake accounts designed to access the...
Anthropic has accused Chinese ecommerce giant Alibaba of obtaining illicit access to Claude by creating fake accounts designed to access the...
Take-Two Interactive (TTWO) investors are waiting years for Grand Theft Auto VI. Makes sense. Few entertainment releases have the same financial heft, cultural reach, or investor expectation. But the bigger story might not be how many copies Rockstar Games sells in the first few weeks. It may be ...
U.S. stocks finished mixed Wednesday as investors cashing out bets on high-flying technology and artificial intelligence companies continued to rotate into beaten-down sectors of the market.
The Baron First Principles ETF has quickly asserted itself as the primary ETF proxy on SpaceX stock.
(Bloomberg) -- A closely watched vote on a tie-up between a Cantor Fitzgerald-linked company and a digital-asset treasury firm led by Adam Back has been delayed.Most Read from BloombergInvestor Who Scored 900% Win in 2008 Crisis Has New Big Short BetStocks Slide as Wall Street Gets AI Wake-Up Call: Markets WrapOracle Cut 21,000 Jobs in 12 Months, Says AI Replaced Some RolesStocks Climb Late After Micron’s Blowout Outlook: Markets WrapThe Debasement Trade Is Unraveling and Kevin Warsh Is One Big
The Federal Reserve said the nation’s largest banks could absorb $708 billion in losses and keep lending, though this year’s stress-test results won’t affect capital requirements.
Micron (MU) delivered earnings and revenue surprises of +17.39% and +12.91%, respectively, for the quarter ended May 2026. Do the numbers hold clues to what lies ahead for the stock?
By Jamie McGeever ORLANDO, Florida, June 24 (Reuters) - U.S. bond yields tumbled on Wednesday as oil's slide to a four-month low eased inflation fears, although the relief wasn't felt as much in
Micron (MU) reported third quarter results on Wednesday after the closing bell. Adjusted earnings per share (EPS) came in at $25.11 (compared to analyst estimates of $20.49), and revenue came in at $41.46 billion (compared to analyst estimates of $35.69 billion). CFRA Research senior vice president and equity analyst Angelo Zino chats with Yahoo Finance about the results.
Investing.com -- JPMorgan Chase & Co. (NYSE:JPM) said its board plans to increase the quarterly common stock dividend to $1.65 per share from $1.50 per share, starting in the third quarter of 2026. The increase is pending board approval at the time of declaration.
Incoming Nike CFO David Denton seen as a stage in its turnaround progress, while earnings call Tuesday could see interest on one-time tariff refund.
Moby summary of Daktronics, Inc.'s Q4 2026 earnings call
The lesson from Micron's blowout Q3 earnings is that AI customers are treating memory like a bottleneck they cannot afford to leave to chance.
The company's valuation is getting out of hand.
Cerebras stock sinks on disappointing Q2 margin guidance. But Morgan Stanley recommends buying the post-earnings dip in CBRS shares.
Anthropic accused Alibaba, the Chinese technology and e-commerce giant, of illicitly extracting its Claude AI model capabilities, calling it the largest known distillation attack on the company to date, according to a letter seen by Reuters.
The offering would be one of the biggest share sales in history, comparable to Saudi Aramco’s 2019 initial public offering and surpassing Alibaba’s U.S. ADR offering in 2014. Micron Technology shares were up about 10% in aftermarket trading. The chip maker reported fiscal third-quarter results after the close that beat consensus revenue and earnings estimates.
Investing.com - Qualcomm Incorporated (NASDAQ:QCOM) unveiled its Dragonfly C1000 data center CPU and secured Meta Platforms as its first major customer on Wednesday, announcing a strategic multi-generation supply agreement at its Investor Day 2026 in New York City. Despite the milestone announcements, Qualcomm shares are trading at $193.61, down 5.15% on the session, as investors weigh the near-term cost of a separate ~$4 billion acquisition against data center revenue that won’t arrive until th
BlackRock (NYSE: BLK) recently recommended Bitcoin (BTC) as a "complementary diversifier" for potentially higher investment returns as the leading cryptocurrency's role in portfolios evolves. Michael Gates, BlackRock's Head of Model Portfolios Solutions, Americas, Multi-Asset Strategies and ...
Micron (MU) reported third quarter results on Wednesday after the closing bell. Adjusted earnings per share (EPS) came in at $25.11 (compared to analyst estimates of $20.49), and revenue came in at $41.46 billion (compared to analyst estimates of $35.69 billion). Yahoo Finance's Josh Lipton takes a closer look at the breaking numbers and guidance.
MEXT bridges the gap between low-cost flash memory and expensive DRAM, helping data centers improve their efficiency as a result.
The stock market is hitting record highs amid an oil shock, rising inflation, and tanking consumer sentiment. But everyone, even billionaires, is going all-in on AI.
Cerebras Systems (CBRS) posted its first earnings report as a public company on Tuesday, and the numbers pulled in opposite directions. Revenue nearly doubled. The stock fell anyway, dropping 10.5% in extended trading, according to a Seeking Alpha report. The disconnect is the story. Cerebras ...
(Bloomberg) -- All of the biggest US banks cleared the Federal Reserve’s annual stress test, setting the stage for lenders to boost buybacks and dividends. Most Read from BloombergInvestor Who Scored 900% Win in 2008 Crisis Has New Big Short BetStocks Slide as Wall Street Gets AI Wake-Up Call: Markets WrapOracle Cut 21,000 Jobs in 12 Months, Says AI Replaced Some RolesChipmakers Fall Anew in Run-Up to Micron’s Results: Markets WrapThe Debasement Trade Is Unraveling and Kevin Warsh Is One Big Rea
Would rising rates change the calculus for the big banks?
Drug companies have found promising new options for one of the most aggressive and hardest-to-treat forms of breast cancer after decades with few breakthroughs. Gilead Sciences won Food and Drug Administration approval Wednesday to sell its drug Trodelvy as a first treatment for newly diagnosed patients with the advanced form of a type of breast cancer known as “triple negative” because it has characteristics that render common treatments ineffective. It is the second such approval in about a month: AstraZeneca and Daiichi Sankyo rival drug, Datroway, was approved for a similar group of patients in May.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
